Cash Flow Statement

Acquisitions Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Change in Working Capital Change in Working Capital Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Depreciation Expense EBIAT Leases Long-Term Debt Issuances Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Short-Term Debt repayments

Ratios

Purple Biotech (PPBT) Shares Issued (2017 - 2025)

Purple Biotech has reported Shares Issued over the past 4 years, most recently at $186000.0 for Q4 2022.

Quarterly Shares Issued rose 129.25% to $186000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2022, up 165.6% year-over-year, with the annual reading at $4.2 million for FY2025, 27.01% down from the prior year.
Shares Issued was $186000.0 for Q4 2022 at Purple Biotech, down from $659000.0 in the prior quarter.
Over five years, Shares Issued peaked at $5.6 million in Q4 2020 and troughed at -$636000.0 in Q4 2021.
The 3-year median for Shares Issued is $423000.0 (2022), against an average of $1.1 million.
Year-over-year, Shares Issued crashed 111.3% in 2021 and then skyrocketed 129.25% in 2022.
A 3-year view of Shares Issued shows it stood at $5.6 million in 2020, then plummeted by 111.3% to -$636000.0 in 2021, then surged by 129.25% to $186000.0 in 2022.
Per Business Quant, the three most recent readings for PPBT's Shares Issued are $186000.0 (Q4 2022), $659000.0 (Q3 2022), and $423000.0 (Q2 2022).